Schedule 13G ownership disclosure
NGM BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 62921N105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,489,149
- Percent of class
- 5.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-016575
- Form type
- SC 13G
- Filer
- NGM BIOPHARMACEUTICALS INC
- CIK
- CIK 1426332
- Filed
- Feb 09, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership